(Q39834090)

English

Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model (English)

1 reference

Europe PubMed Central

15 September 2017

Pseudomonas aeruginosa

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Blaser J

1

1 reference

Europe PubMed Central

15 September 2017

Stone BB

2

1 reference

Europe PubMed Central

15 September 2017

Groner MC

3

1 reference

Europe PubMed Central

15 September 2017

Zinner SH

4

1 reference

Europe PubMed Central

15 September 2017

language of work or name

0 references

publication date

1 July 1985

1 reference

Europe PubMed Central

15 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

15 September 2017

28

1 reference

Europe PubMed Central

15 September 2017

64-68

1 reference

Europe PubMed Central

15 September 2017

1

1 reference

Europe PubMed Central

15 September 2017

Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176311

22 September 2017

Comparative Multiple-Dose Pharmacokinetics of Cefotaxime, Moxalactam, and Ceftazidime

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176311

22 September 2017

Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176311

22 September 2017

Ceftazidime compared to tobramycin and ticarcillin in immunocompromised haematological patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176311

25 September 2017

Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176311

15 June 2018

Two compartment kinetic model with multiple artificial capillary units

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176311

20 August 2018

Biological variability of multiple dose pharmacokinetics of netilmicin in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/3929682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Monotherapy of systematic Pseudomonas aeruginosa infections with ceftazidime. The causes of therapeutic failures]

1 reference

https://pubmed.ncbi.nlm.nih.gov/3929682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime versus tobramycin/ticarcillin in treating hospital acquired pneumonia and bacteremia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3929682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.28.1.64

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39834090&oldid=2143352773"